Evidence map›Paper›PMID 35368853›Full record

ArticleContraception: X2022

Measuring experiences and concerns surrounding contraceptive induced side-effects in a nationally representative sample of contraceptive users: Evidence from PMA Ethiopia.

Linnea A Zimmerman, Dana O Sarnak, Celia Karp, Shannon N Wood, Mahari Yihdego, Solomon Shiferaw, Assefa Seme

Open access · goldAbstract read
In one paragraph

Article in Contraception: X, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Linnea A ZimmermanDepartment of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public health, Baltimore, MD, United States.
Dana O SarnakDepartment of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public health, Baltimore, MD, United States.
Celia KarpDepartment of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public health, Baltimore, MD, United States.
Shannon N WoodDepartment of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public health, Baltimore, MD, United States.
Mahari YihdegoPMA-Ethiopia, Addis Ababa University, Addis Ababa, Ethiopia.
Solomon ShiferawSchool of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Assefa SemeSchool of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Johns Hopkins University · USAddis Ababa University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Our objectives were to assess the prevalence of specific side-effects experienced by current and recent contraceptive users, describe patterns of side-effects that users were concerned about, and share measurement lessons learned. Study design: Data come from the PMA Ethiopia 2019 nationally-representative, cross-sectional survey. Our analytic sample included women who were current (weighted Results: Among current users, 648/2190 women (30%) reported experiencing any side-effect, while 252/644 (40%) of recent users reported ever experiencing any side-effect. Bleeding changes were reported most frequently and were higher among implant and injectable users. More recent users reported side-effects that were associated with physical discomfort, such as headaches, than current users. About one-third of current and recent users reported being concerned about at least one side-effect that they had not experienced, with about 15% of current and recent users reporting concerns about bleeding changes (307/2190 and 112/627, respectively) and concerns about physical discomfort (334/2019 and 98/627, respectively). Conclusions: While bleeding changes are common, users report a range of side-effects related to physical discomfort underscoring the need for comprehensive counseling. We highlight challenges in measuring side-effects using quantitative tools and pose recommendations for future research and measurement efforts. Implications: : Experiencing and fearing contraceptive-induced menstrual bleeding changes and physical discomfort, particularly headaches, is high among hormonal contraceptive and IUD users in Ethiopia. counseling that addresses an array of side-effects is needed. Additional research is also needed to disentangle the effect of experiencing versus fearing side-effects on contraceptive use.

Indexed as

Contraceptive-induced menstrual bleeding changesContraceptive side-effectsEthiopia

Identifiers

PMID35368853
PMCPMC8971853
OpenAlexW4220820570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.